GlassScriptPhysician profile
Elizabeth Oconnor
NPI 1104849652
$1,208.84
in general payments reported to CMS, 2019-2025
12 companies · $300 in 2025
The $300 reported for 2025 was more than what 94% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.53 · 2022: $211 · 2023: $337 · 2024: $339 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $976.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $491.65 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $155.72 | 2022-2025 | Entyvio, Eohilia |
| Regeneron Healthcare Solutions, INC. | $124.84 | 2022-2025 | Dupixent |
| Ardelyx, INC. | $112.02 | 2023-2025 | Ibsrela |
| Janssen Biotech, INC. | $77.54 | 2023-2025 | Stelara, Simponi, Simponi Aria |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.37 | 2022-2024 | Trulance |
| Intercept Pharmaceuticals, INC. | $52.96 | 2023-2025 | Ocaliva |
| Boston Scientific Corporation | $48.84 | 2024 | Orcapod |
| Genzyme Corporation | $39.24 | 2024 | |
| Braintree Laboratories, INC. | $20.15 | 2023 | Sutab |
| Nestle Healthcare Nutrition INC. | $17.73 | 2022 | |
| Organon LLC | $12.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Oconnor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.